| Identification | Back Directory | [Name]
Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride | [CAS]
5897-18-7 | [Synonyms]
Cyclizine 2HCl
Marzine hydrochloride
Cyclizine 2hydrochloride
Cyclizine dihydrochloride
Piperazine, 1-benzhydryl-4-methyl-, dihydrochloride
1-Diphenylmethyl-4-methylpiperazine dihydrochloride
Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride
Piperazine, 1-(diphenylmethyl)-4-methyl-, hydrochloride (1:2)
Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride USP/EP/BP | [Molecular Formula]
C18H24Cl2N2 | [MDL Number]
MFCD01702954 | [MOL File]
5897-18-7.mol | [Molecular Weight]
339.303 |
| Hazard Information | Back Directory | [Biological Activity]
Cyclizine 2HCl is a piperazine derivative with Histamine H1 receptor antagonist activity. | [in vitro]
Cyclizine is a piperazine histamine H1 receptor antagonist and has anticholinergic and antiemetic properties. It increases lower esophageal sphincter tone and reduces the sensitivity of tortuous organs. | [in vivo]
Cyclizine is metabolized to its N-desmethyl derivative, Norcyclizine, which has little antihistamine (H1) activity compared to Cyclizine. After oral administration of Cyclizine, the effect will be produced within 30 minutes, and the maximum effect will be achieved within 1-2 hours, which can last for 4-6 hours. Cyclizine administered orally at a dose of 50 mg alone in healthy adult volunteers produced peak plasma concentrations of approximately 70 ng/mL two hours after dosing. The plasma elimination half-life is about 20 hours. | [target]
| Target | Value | | Histamine H1 receptor |
|
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310 |
| Website: |
http://www.weikeqi-biotech.com/ |
| Company Name: |
InvivoChem
|
| Tel: |
13549236410 |
| Website: |
https://www.invivochem.cn/ |
|